Dengue and severe dengue fever: comparison of clinical characteristics, haematological and biochemical parameters in a tertiary care hospital

Tahmina Zahan Munna; Morshed Nasir; Afzal Akhter; Parvin Sultana; Bhabna Ghosh; Rushnat Zahin Hoque

doi:10.18203/2319-2003.ijbcp20261106

Authors

Tahmina Zahan Munna Department of Pharmacology & Therapeutics, Holy Family Red Crescent Medical College, Dhaka, Bangladesh
Morshed Nasir Department of Pharmacology & Therapeutics, Holy Family Red Crescent Medical College, Dhaka, Bangladesh
Afzal Akhter Registrar of Medicine, Holy Family Red Crescent Medical College Hospital, Mogbazar, Dhaka, Bangladesh
Parvin Sultana Department of Paediatrics, Holy Family Red Crescent Medical College Hospital, Mogbazar, Dhaka, Bangladesh
Bhabna Ghosh Holy Family Red Crescent Medical College Hospital, Dhaka, Bangladesh
Rushnat Zahin Hoque Holy Family Red Crescent Medical College Hospital, Dhaka, Bangladesh

DOI:

https://doi.org/10.18203/2319-2003.ijbcp20261106

Keywords:

Dengue, Warning sign, Antibiotics, Corticosteroid, Haematological

Abstract

Background: Dengue is a mosquito-borne viral disease worldwide. The number of new cases and death in Bangladesh increased in current years. The aim of the study was to detect the difference between demo-graphic data, warning signs, comorbidity, treatment pattern, and laboratory investigations in two different types of dengue fever during the pick season.

Methods: This retrospective observational study was done in Holy Family Red Crescent Medical College from May to October 2021 from records of hospital on a total of 113 dengue NS1, IgG and IgM positive patients. The classical dengue fever (CDF) group consists of 76 and dengue hemorrhagic fever (DHF) group consists of 37 patients. Socio-demographic data, co-morbidity (DM, HTN, Bronchial Asthma, COVID-19), ‘warning sign’ (abdominal tenderness, mucosal bleeding, lethargy, restlessness, persistent vomiting, clinical fluid accumulation, liver enlargement >2cm, increase HCT, decrease Platelet), treatment pattern, and laboratory findings were assembled, analyzed and compared between two groups.

Results: Out of 113 patients, the majority were male. The mean age of patients was (26.0±15.8 and 27.7±17.2) in CDF and DHF. The mean duration of hospital stay was slightly longer in DHF (6.78±2.1 days) compared to CDF patients (6.13±1.45 days). The co-morbidities were similar between groups. Among warning signs, only mucosal bleeding was significantly more in DHF (37.8%) than in CDF patients (7.9%) (p <0.001). Similarly, decreased HCT and clinical fluid accumulation were significantly higher in the DHF group (p <0.001 and p=0.024).

Conclusions: The frequency of CDF was higher than DHF, but the ‘warning sign’ and significant thrombocytopenia and leucopenia in DHF reflect the progression to dengue shock syndrome.

References

Guo C, Zhou Z, Wen Z, Liu Y, Zeng C, Xiao D, et al. Global Epidemiology of Dengue Outbreaks in 1990-2015: A Systematic Review and MetaAnalysis. Front Cell Infect Microbiol. 2017;7:317.

Garg P, Nagpal J, Khairnar P, Seneviratne SL. Economic burden of dengue infections in India. Trans R Soc Trop Med Hyg. 2008;102(6):570-7.

Harving ML, Rönsholt FF. The economic impact of dengue hemorrhagic fever on family level in Southern Vietnam. Dan Med Bull. 2007;54(2).

Whitehorn J, Farrar J. Dengue. Br Med Bull. 2010; 95(1):161-73.

Chen LH, Wilson ME. Dengue and chikungunya infections in travelers. Curr Opin Infect Dis. 2010; 23(5):438-44.

Ranjit S, Kissoon N. Dengue hemorrhagic fever and shock syndromes. Pediatr Crit Care Med. 2011;12(1):90-100.

WHO. Dengue: guidelines for diagnosis, treatment, prevention and control. Geneva: World Health Organization. 2009. Available at: https://iris.who.int/handle/10665/44188. Accessed on 30 December 2025.

Rahman M, Rahman K, Siddque AK, Shoma S, Kamal AH, Ali KS, et al. First Outbreak of Dengue Hemorrhagic Fever, Bangladesh. Emerg Infect Dis. 2002;8(7):738-40.

Mahmood B, Mahmood S. Emergence of dengue in Bangladesh a major international pub lic health concern in recent years. J Environ Res Manage. 2011; 2(3):35-41.

WHO. Dengue hemorrhagic fever: early recognition, diagnosis and hospital management Geneva An audiovisual guide for health-care workers responding to outbreaks World Health Organization. 2006. Available at: https://www. who.int/csr/don/archive/disease/dengue_fever/ dengue.pdf. Accessed on 30 December 2025.

DGHS. National Guideline for Clinical Management of Dengue Syndrome. 2018. Available at: https://dghs.gov.bd/index.php/en/home/5431revised-guideline-for-clinical management-of-dengue. Accessed on 30 December 2025.

Zhang F, Kramer CV. 2014. Available at: https://pubmed.ncbi.nlm.nih.gov/24984082/. Accessed on 30 December 2025.

Wiwanitkit V. Liver dysfunction in dengue infection, an analysis of the previously published Thai cases. J Ayub Med Coll Abbottabad. 2007;19(1):10-1.

Petdachai W. Hepatic dysfunction in children with dengue shock syndrome. Dengue Bull. 2005;29:112-7.

Jagadish KK, Jain P, Manjunath VG, Umesh L. Hepatic involvement in Dengue fever in children. Iran J Pediatr. 2012;22(2):231-6.

Lee LK, Gan VC, Lee VJ, Leo YS, Lye DC, Oh HM, et al. Clinical relevance and discriminatory value of elevated liver aminotransferase levels for dengue severity. PLoS Negl Trop Dis. 2012;6:e1676.

Zubair A, Qureshi AA, Jafri SAM. Assessment of Dengue Fever Severity Through Liver Function Test. 2026. Available at: https://www.intechopen.com/chapters/56427?. Accessed on 30 December 2025.

Ministry of Health Sri Lanka. National guidelines on management of Dengue fever and Dengue hemorrhagic fever in children and adolescent. 2010. Available at: http://www.epid.gov.lk/web/images/pdf/Publication/gmdfca12.pdf. Accessed on 30 December 2025.

Kurane I. Dengue hemorrhagic fever with special emphasis on immunopathogenesis. Comp Immunol Microbiol Infect Dis. 2007;30(6):329-40.

Islam MA, Ahmed MU, Begum N, Khan WA, Rahman M, Khan SI, et al. Molecular characterization and Clinical evaluation of dengue outbreak in 2002 in Bangladesh. Jpn J Infect Dis. 2006;59:85-91.

Ahmad FU, Paul SK, Aung MS, Mazid R, Alam M, Ahmed S, et al. Co-circulation of dengue virus type 3-genotype I and type 2-cosmopolitan genotype in 2018 outbreak in Dhaka, Bangladesh. New Infect. 2020;33:100629.

Muraduzzaman AKM, Alam AN, Sultana S, Rahman M, Haque CE, Kabir Y, et al. Circulating dengue virus serotypes in Bangladesh from 2013 to 2016. Virus Dis. 2018;29(3):303-7.

Biswas HH, Gordon A, Nuñez A, Perez MA, Balmaseda A, Harris E. Lower low-density lipoprotein cholesterol levels are associated with severe dengue outcome. PLoS Negl Trop Dis. 2015; 9(9):e0003904.

Mallhi TH, Khan AH, Adnan AS, Sarriff A, Habib Khan Y, Jummaat F. Clinico-laboratory spectrum of dengue viral infection and risk factors associated with dengue hemorrhagic fever: a retrospective study. BMC Infect Dis. 2015;15:399.

Karnal AHM, Mollah KH, Begum A Siddiqa, Khoda K, Tanzeem S, Sultana N. Dengue Fever: Study of 100 Cases in a tertiary care hospital in Dhaka City. J Med Sci Res. 2015;24(1):3-7.

Ahmad SN, Anisujjaman QM, Sakib N, Mahmud ZH, Rahman MM, Hossain MI. Dengue 2019 — A change in perspective of clinical presentations and laboratory finding. 2019.

Mohammad H, Sarkar DN, Amin MR, Basher A, Ahmed T. Clinical Profile and Outcome of Patients with Dengue Syndrome in Hospital Care. J Med. 2011;12(2):131-8.

Perveen RA, Nasir M, Parveen S, Zahan T, Farha N, Islam MA. Classical and Hemorrhagic Dengue among Bangladeshi Adults:ASingle Center Cohort Study. JMRHS. 2021;4(4):1238-44.

WHO. Dengue hemorrhagic fever: early recognition, diagnosis and hospital management Geneva An audiovisual guide for health-care workers responding to outbreaks World Health Organization. 2006. Available at: https://www. who.int/csr/don/archive/disease/dengue_fever/dengue.pdf. Accessed on 30 December 2025.

DGHS. National Guideline for Clinical Management of Dengue Syndrome. 2018. Available at: https://dghs.gov.bd/index.php/en/home/5431revised-guideline-for-clinical management-of-dengue. Accessed on 30 December 2025.

Sellahewa KH, Samaraweera N, Thusita KPGD, Fernando JLIN. Is fresh frozen plasma effective for thrombocytopenia in adults with dengue fever? A prospective randomised double blind controlled study. Ceylon Med J. 2008;53(2):36-40.

Rammohan S, Bhandare B, E A, Gopinath R, Gitanjali B. The prescribing pattern for the management of dengue fever in pediatric patients of a tertiary care hospital: an observational study. Int J Basic Clin Pharmacol. 2018;7(12):2384-8.

Adrizain R, Setiabudi D, Chairulfatah A. The inappropriate use of antibiotics in hospitalized dengue virus-infected children with presumed concurrent bacterial infection in teaching and private hospitals in Bandung, Indonesia. PLOS Negl Trop Dis. 2019;13(6):e0007438.

Rajapakse S, De Silva NL, Weeratunga P, Rodrigo C, Fernando SD. Prophylactic and therapeutic interventions for bleeding in dengue: a sys tematic review. Trans R Soc Trop Med Hyg. 2017; 111(10):433-9.

Manam G, Godavarthi RM, Baru R, Sunitha S, Duddu GS. Evaluation of Ultrasonographic Findings in Dengue Fever Cases during an Outbreak at a Tertiary Care Hospital of South India. Int J Contemp Med Surg Radiol. 2018;3(2):106-10.